Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis

Journal of Medical and Veterinary Mycology

Volumn 34, Issue 5, 1996, Pages 337-339

  Lynch, M E ^a   Sobel, J D ^a   Fidel Jr , P L ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Antifungal drug resistance; Antifungal susceptibility testing; Candida albicans; Recurrent vaginitis

Indexed keywords

CLOTRIMAZOLE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE;

ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NONHUMAN; RECURRENT DISEASE; VAGINA CANDIDIASIS;

CANDIDA ALBICANS;

EID: 80051479565     PISSN: 02681218     EISSN: None     Source Type: Journal    
DOI: 10.1080/02681219680000571     Document Type: Article

References (15)

1. Sobel JD. Vaginal infections in adult women. Med Clin North Am 1990; 74: 1573-602.
2. Hurley R, De Louvois J. Candida vaginitis. Postgrad Med J 1979; 55: 645-7.
3. Klein RS, Harris CA, Small CB, et al. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunologic deficiency syndrome. New Engl J Med 1984; 311: 354-8.
4. Clift RA. Candidiasis in the transplant patient. Am J Med 1984; 77(Suppl. 4D): 34-8.
5. Boken DJ, Swindells S, Rinaldi MG. Fluconazole-resistant Candida albicans. Clin Inject Dis 1993; 17: 1018-21.
6. Newman SL, Flanigan TP, Fisher A, et al. Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS. Clin Infect Dis 1994; 19: 684-6.
7. Sobel JD, Vazquez J. Symptomatic vaginitis due to fluconazole resistant C. albicans in an HIV-negative female. Clin Infect Dis 1996; 22: 726-7.
8. Warren NG, Shadomy HJ. Yeasts of medical importance. In: Balows A, Hausler WJ Jr, Herrmann HD, Isenberg HD, Shadomy HJ (eds). Manual of Clinical Microbiology, 5th edn. Washington, DC: American Society for Microbiology, 1991; 617-29.
9. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing for yeasts. Proposed standard. National Committee for Clinical Laboratory Standards, Villanova, PA. 1995: document M27-T.
10. Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis 1994; 18: 240-2.
11. Willocks L, Leen CLS, Brettle RP, et al. Fluconazole resistance in AIDS patients. J Antimicrob Chemother 1991; 28: 937-9.
12. Fong IW, Bannatyne RM, Wong P. Lack of in vitro resistance of Candida albicans to ketoconazole, itraconazole and clotrimazole in women treated for recurrent vaginal candidiasis. Genitourin Med 1993; 69: 44-6.
13. Horowitz BJ, Giaquinta D, Ito S. Evolving pathogens in vulvovaginal candidiasis: implications for patient care. J Clin Pharmacol 1992; 32: 248-55.
14. Spinillo A, Nicola S, Colonna L, et al. Frequency and significance of drug resistance in vulvovaginal candidiasis. Gynecol Obstet Invest 1994; 38: 130-3.
15. Redondo-Lopez V, Lynch M, Schmitt C, Cook R, Sobel JD. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents. Obstet Gynecol 1990; 76: 651-5.